Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2010-12, Vol.17 (6), p.1351-1361
Main Authors: Rimawi, Mothaffar F., Wiechmann, Lisa S., Wang, Yen-Chao, Huang, Catherine, Migliaccio, Ilenia, Wu, Meng-Fen, Gutierrez, Carolina, Hilsenbeck, Susan G., Arpino, Grazia, Massarweh, Suleiman, Ward, Robin, Soliz, Robert, Osborne, C. Kent, Schiff, Rachel
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1361
container_issue 6
container_start_page 1351
container_title Clinical cancer research
container_volume 17
creator Rimawi, Mothaffar F.
Wiechmann, Lisa S.
Wang, Yen-Chao
Huang, Catherine
Migliaccio, Ilenia
Wu, Meng-Fen
Gutierrez, Carolina
Hilsenbeck, Susan G.
Arpino, Grazia
Massarweh, Suleiman
Ward, Robin
Soliz, Robert
Osborne, C. Kent
Schiff, Rachel
description
doi_str_mv 10.1158/1078-0432.CCR-10-1905
format article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3060302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_3060302</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30603023</originalsourceid><addsrcrecordid>eNqljU1OwzAQhb0A0fJzBKS5QFo7PzRsWLQUFQmJKsqCXTRJJomhsSPbaWlvw01JK4TEmtW8eW_mfYzdCj4RIoqngs9ij4eBP1ksEk9wT9zz6IyNf_0Ru7T2nXMRCh5esJEvRBDH0WzMvhIq-4JKeNSWAFUJz8qRaaVzpBykhtC1R7WTroEX7NBJJfPTZWrQuv7Qt5hDpQ2s9elnvtHFB5YEugLXEKyWCazRNTvcg1TH1fOninp43ZKhz86QtVLVMB9YdkD27dD1RkrXBitnr9l5hRtLNz_zij08LdPFyuv6vKWyGJAGN1lnZItmn2mU2d9EySar9TYL-B0PuB_8u-Abew16Tw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts</title><source>Science Journals (Open access)</source><creator>Rimawi, Mothaffar F. ; Wiechmann, Lisa S. ; Wang, Yen-Chao ; Huang, Catherine ; Migliaccio, Ilenia ; Wu, Meng-Fen ; Gutierrez, Carolina ; Hilsenbeck, Susan G. ; Arpino, Grazia ; Massarweh, Suleiman ; Ward, Robin ; Soliz, Robert ; Osborne, C. Kent ; Schiff, Rachel</creator><creatorcontrib>Rimawi, Mothaffar F. ; Wiechmann, Lisa S. ; Wang, Yen-Chao ; Huang, Catherine ; Migliaccio, Ilenia ; Wu, Meng-Fen ; Gutierrez, Carolina ; Hilsenbeck, Susan G. ; Arpino, Grazia ; Massarweh, Suleiman ; Ward, Robin ; Soliz, Robert ; Osborne, C. Kent ; Schiff, Rachel</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>DOI: 10.1158/1078-0432.CCR-10-1905</identifier><identifier>PMID: 21138857</identifier><language>eng</language><ispartof>Clinical cancer research, 2010-12, Vol.17 (6), p.1351-1361</ispartof><rights>Copyright © 2010 American Association for Cancer Research 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Rimawi, Mothaffar F.</creatorcontrib><creatorcontrib>Wiechmann, Lisa S.</creatorcontrib><creatorcontrib>Wang, Yen-Chao</creatorcontrib><creatorcontrib>Huang, Catherine</creatorcontrib><creatorcontrib>Migliaccio, Ilenia</creatorcontrib><creatorcontrib>Wu, Meng-Fen</creatorcontrib><creatorcontrib>Gutierrez, Carolina</creatorcontrib><creatorcontrib>Hilsenbeck, Susan G.</creatorcontrib><creatorcontrib>Arpino, Grazia</creatorcontrib><creatorcontrib>Massarweh, Suleiman</creatorcontrib><creatorcontrib>Ward, Robin</creatorcontrib><creatorcontrib>Soliz, Robert</creatorcontrib><creatorcontrib>Osborne, C. Kent</creatorcontrib><creatorcontrib>Schiff, Rachel</creatorcontrib><title>Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts</title><title>Clinical cancer research</title><issn>1078-0432</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqljU1OwzAQhb0A0fJzBKS5QFo7PzRsWLQUFQmJKsqCXTRJJomhsSPbaWlvw01JK4TEmtW8eW_mfYzdCj4RIoqngs9ij4eBP1ksEk9wT9zz6IyNf_0Ru7T2nXMRCh5esJEvRBDH0WzMvhIq-4JKeNSWAFUJz8qRaaVzpBykhtC1R7WTroEX7NBJJfPTZWrQuv7Qt5hDpQ2s9elnvtHFB5YEugLXEKyWCazRNTvcg1TH1fOninp43ZKhz86QtVLVMB9YdkD27dD1RkrXBitnr9l5hRtLNz_zij08LdPFyuv6vKWyGJAGN1lnZItmn2mU2d9EySar9TYL-B0PuB_8u-Abew16Tw</recordid><startdate>20101207</startdate><enddate>20101207</enddate><creator>Rimawi, Mothaffar F.</creator><creator>Wiechmann, Lisa S.</creator><creator>Wang, Yen-Chao</creator><creator>Huang, Catherine</creator><creator>Migliaccio, Ilenia</creator><creator>Wu, Meng-Fen</creator><creator>Gutierrez, Carolina</creator><creator>Hilsenbeck, Susan G.</creator><creator>Arpino, Grazia</creator><creator>Massarweh, Suleiman</creator><creator>Ward, Robin</creator><creator>Soliz, Robert</creator><creator>Osborne, C. Kent</creator><creator>Schiff, Rachel</creator><scope>5PM</scope></search><sort><creationdate>20101207</creationdate><title>Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts</title><author>Rimawi, Mothaffar F. ; Wiechmann, Lisa S. ; Wang, Yen-Chao ; Huang, Catherine ; Migliaccio, Ilenia ; Wu, Meng-Fen ; Gutierrez, Carolina ; Hilsenbeck, Susan G. ; Arpino, Grazia ; Massarweh, Suleiman ; Ward, Robin ; Soliz, Robert ; Osborne, C. Kent ; Schiff, Rachel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30603023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rimawi, Mothaffar F.</creatorcontrib><creatorcontrib>Wiechmann, Lisa S.</creatorcontrib><creatorcontrib>Wang, Yen-Chao</creatorcontrib><creatorcontrib>Huang, Catherine</creatorcontrib><creatorcontrib>Migliaccio, Ilenia</creatorcontrib><creatorcontrib>Wu, Meng-Fen</creatorcontrib><creatorcontrib>Gutierrez, Carolina</creatorcontrib><creatorcontrib>Hilsenbeck, Susan G.</creatorcontrib><creatorcontrib>Arpino, Grazia</creatorcontrib><creatorcontrib>Massarweh, Suleiman</creatorcontrib><creatorcontrib>Ward, Robin</creatorcontrib><creatorcontrib>Soliz, Robert</creatorcontrib><creatorcontrib>Osborne, C. Kent</creatorcontrib><creatorcontrib>Schiff, Rachel</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rimawi, Mothaffar F.</au><au>Wiechmann, Lisa S.</au><au>Wang, Yen-Chao</au><au>Huang, Catherine</au><au>Migliaccio, Ilenia</au><au>Wu, Meng-Fen</au><au>Gutierrez, Carolina</au><au>Hilsenbeck, Susan G.</au><au>Arpino, Grazia</au><au>Massarweh, Suleiman</au><au>Ward, Robin</au><au>Soliz, Robert</au><au>Osborne, C. Kent</au><au>Schiff, Rachel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts</atitle><jtitle>Clinical cancer research</jtitle><date>2010-12-07</date><risdate>2010</risdate><volume>17</volume><issue>6</issue><spage>1351</spage><epage>1361</epage><pages>1351-1361</pages><issn>1078-0432</issn><pmid>21138857</pmid><doi>10.1158/1078-0432.CCR-10-1905</doi></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2010-12, Vol.17 (6), p.1351-1361
issn 1078-0432
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3060302
source Science Journals (Open access)
title Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Dose%20and%20Intermittent%20Treatment%20with%20Lapatinib%20and%20Trastuzumab%20for%20Potent%20Blockade%20of%20the%20HER%20Pathway%20in%20HER-2/neu%20Overexpressing%20Breast%20Tumor%20Xenografts&rft.jtitle=Clinical%20cancer%20research&rft.au=Rimawi,%20Mothaffar%20F.&rft.date=2010-12-07&rft.volume=17&rft.issue=6&rft.spage=1351&rft.epage=1361&rft.pages=1351-1361&rft.issn=1078-0432&rft_id=info:doi/10.1158/1078-0432.CCR-10-1905&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_3060302%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30603023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/21138857&rfr_iscdi=true